Related Experiment Video
Updated: Jul 12, 2026

In Situ Exploration of Murine Megakaryopoiesis using Transmission Electron Microscopy
Published on: September 8, 2021
Menin in normal and malignant megakaryopoiesis
1Leukemia Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
None:
Severe thrombocytopenia is a known complication of menin inhibitor therapy; however, the mechanism underlying this effect is unknown. In this issue of Cancer Cell, Wen et al. demonstrate that menin is a key component of normal megakaryopoiesis and establish menin as a therapeutic vulnerability in myeloproliferative neoplasms.
Related Concept Videos
Abnormal Proliferation
Abnormal Proliferation
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Production of Formed Elements
Most HSCs commit to...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

